An immunoassay for the measurement of sirolimus.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0149-2918(00)89022-0PMID 10823373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection.

  2000cited by this paper
• Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

  1999cited by this paper
• Therapeutic drug monitoring of immunosuppressant drugs.

  1999cited by this paper
• Species differences in sirolimus stability in humans, rabbits, and rats.

  1998cited by this paper
• Emerging strategies for the clinical application of rapamycin.

  1998cited by this paper
• Pharmacodynamic monitoring of immunosuppressive drugs.

  1998cited by this paper
• Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.

  1998cited by this paper
• Clinical application of immunosuppressive agents in renal transplantation.

  1998cited by this paper
• Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.

  1998cited by this paper
• Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients.

  1997cited by this paper
• Determination of rapamycin in whole blood by HPLC.

  1997cited by this paper
• Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection.

  1996cited by this paper
• Pharmacodynamic monitoring of immunosuppressive drugs.

  1996cited by this paper
• Analysis of Method Comparison Studies

  1996cited by this paper
• Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry.

  1996cited by this paper
• Determination of Rapamycin in Whole Blood by HPLC

  1995cited by this paper
• Consensus Guidelines for Therapeutic Drug Monitoring of Rapamycin: Report of the Consensus Panel

  1995cited by this paper
• Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action

  1995cited by this paper
• Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations.

  1994cited by this paper
• Blood distribution of rapamycin.

  1993cited by this paper
• Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography.

  1992cited by this paper
• Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin.

  1992cited by this paper
• Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase

  1992cited by this paper

• Analytical Method Validation for the Detection of the Drug Sirolimus in Sugar-Coated Tablet using HPLC-DAD

  2025cites this paper
• Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies

  2022cites this paper
• Determination of sirolimus in blood by high-performance liquid chromatography with ultraviolet detection - Experience and review

  2020cites this paper
• Development of a precise quantitative method for monitoring sirolimus in whole blood using LC/ESI-MS/MS.

  2020cites this paper
• Application of liquid chromatography combined with mass spectrometry or tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants

  2016cites this paper
• Interactions Between Sirolimus and Anti-Inflammatory Drugs: Competitive Binding for Human Serum Albumin.

  2016cites this paper
• Analytical Methodologies for the Determination of Sirolimus: A Review.

  2014cites this paper
• The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers

  2013cites this paper
• A Reversed Phase High Performance Liquid Chromatographic Method for Determination of Rapamycin

  2013cites this paper
• Use of Sirolimus in Solid Organ Transplantation

  2012cites this paper
• Development and validation of an HPLC method for the analysis of sirolimus in drug products.

  2012influential citation
• A Review on Therapeutic Drug Monitoring of Immunosuppressant Drugs

  2011cites this paper
• Analytical and pharmacological aspects of therapeutic drug monitoring of mTOR inhibitors.

  2011cites this paper
• An accurate quantitative LC/ESI-MS/MS method for sirolimus in human whole blood.

  2011cites this paper
• HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites

  2011cites this paper
• Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods.

  2011cites this paper
• Evaluation of the Abbott ARCHITECT i2000 Sirolimus Assay and Comparison With the Abbott IMx Sirolimus Assay and an Established Liquid Chromatography–Tandem Mass Spectrometry Method

  2011cites this paper
• Category : Analytical

  2011cites this paper
• Repeat-dose sirolimus pharmacokinetics and pharmacodynamics in patients with hepatic allografts

  2011cites this paper
• Liquid chromatographic method for the determination of sirolimus in blood using electrochemical detection.

  2009cites this paper
• Characterization of sirolimus metabolites in pediatric solid organ transplant recipients

  2009influential citation
• Immunosuppressive Drugs: Pharmacokinetics, Preanalytic Variables, and Analytical Considerations

  2008cites this paper
• Crossreactivity of Isolated Everolimus Metabolites With the Innofluor Certican Immunoassay for Therapeutic Drug Monitoring of Everolimus

  2007cites this paper
• Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients.

  2007cites this paper
• A Comparative Study of Sirolimus Tablet Versus Oral Solution for Prophylaxis of Acute Renal Allograft Rejection

  2006cites this paper
• Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: comparison of methods

  2006cites this paper
• Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.

  2006cites this paper
• Comparación de la cromatografía líquida de alta resolución frente al enzimoinmunoensayo de micropartículas para la determinación de sirolimus en trasplante renal

  2006cites this paper
• [Comparison of high-resolution liquid chromatography versus microparticle enzyme immunoassay for the measurement of sirolimus levels in renal transplantation].

  2006cites this paper
• Evaluation of an immunoassay (Abbott-IMX Analyzer) allowing routine determination of sirolimus: comparison with LC-MS method.

  2006cites this paper
• Clinical use of immunosuppressants

  2005cites this paper
• Sirolimus quantification by high‐performance liquid chromatography with ultraviolet detection

  2005cites this paper
• Sirolimus: the evidence for clinical pharmacokinetic monitoring.

  2005cites this paper
• An evaluation of the Abbott IMx sirolimus assay in relation to a high-performance liquid chromatography-ultraviolet method

  2005cites this paper
• Immunosuppression for pancreas transplantation

  2005cites this paper
• The relative proportions of sirolimus metabolites in blood using HPLC with mass-spectrometric detection.

  2004cites this paper
• A microparticle enzyme immunoassay to measure sirolimus.

  2004cites this paper
• Sirolimus: a ten-year perspective.

  2004cites this paper
• Exposure-response relationships and drug interactions of sirolimus

  2004cites this paper
• Chapter 11 – Monitoring immunosuppressive drugs

  2004cites this paper
• [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2].

  2003cites this paper
• Therapeutic monitoring of sirolimus: its contribution to optimal prescription.

  2003cites this paper
• Sirolimus: a current perspective.

  2003cites this paper
• International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology Working Group on Immunosuppressive Drug Monitoring

  2002cites this paper
• A Clinical Pharmacokinetic Study of Tacrolimus and Sirolimus Combination Immunosuppression Comparing Simultaneous to Separated Administration

  2002cites this paper
• Sirolimus: has it gained from experience with older drugs?

  2002cites this paper
• Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination1, 2

  2002cites this paper
• Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

  2002cites this paper
• Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.

  2001cites this paper
• SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10

  2001cites this paper
• Rapamycin in transplantation: a review of the evidence.

  2001cites this paper
• Immunosuppressant drugs--the role of therapeutic drug monitoring.

  2001cites this paper
• Orthotopic liver transplantation using low‐dose tacrolimus and sirolimus

  2001cites this paper
• Median effect analysis of efficacy versus adverse effects of immunosuppressants

  2001cites this paper
• Rapamycin: clinical results and future opportunities.

  2001cites this paper
• From Beach to Bedside: History of the Development of Sirolimus

  2001cites this paper
• Therapeutic drug monitoring for immunosuppressants.

  2001cites this paper
• Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

  2000cites this paper
• Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection.

  2000cites this paper
• Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus.

  2000cites this paper
• Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection.

  2000cites this paper
• Advances in therapeutic drug monitoring for immunosuppressants: a review of sirolimus. Introduction and overview.

  2000cites this paper
• Proficiency-testing issues relating to sirolimus.

  2000cites this paper
• The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients.

  2000cites this paper
• Simultaneous Quantification of Tacrolimus and Sirolimus, in Human Blood, by High-Performance Liquid Chromatography–Tandem Mass Spectrometry

  2000cites this paper
• Enzymatic assay of calcium in serum with phospholipase D.

  1999cites this paper
• Analytical performance of microparticle enzyme immunoassay and HPLC-tandem mass spectrometry in the determination of sirolimus in whole blood.

  1999cites this paper
• Therapeutic drug monitoring of immunosuppressant drugs.

  1999cites this paper
• Analytical Performance of Microparticle Enzyme Immunoassay and HPLC-Tandem Mass Spectrometry in the Determination of Sirolimus in Whole Blood

  year unknowncites this paper